Xue-Qing Yu - Search Results

Year	Number of Results
2004	4
2005	4
2006	4
2007	16
2008	7
2009	6
2010	8
2011	13
2012	11
2013	14
2014	8
2015	6
2016	3
2017	5
2018	5
2019	9
2020	10
2021	4
2022	10
2023	6
2024	1

1

Quantum spin driven Yu-Shiba-Rusinov multiplets and fermion-parity-preserving phase transition in K₃C₆₀.

Wang SZ, Yu XQ, Wei LX, Wang L, Cheng QJ, Peng K, Cheng FJ, Liu Y, Li FS, Ma XC, Xue QK, Song CL. Wang SZ, et al. Among authors: yu xq. Sci Bull (Beijing). 2024 Mar 27:S2095-9273(24)00208-1. doi: 10.1016/j.scib.2024.03.052. Online ahead of print. Sci Bull (Beijing). 2024. PMID: 38594099

2

A pedigree with retinitis pigmentosa and its concomitant ophthalmic diseases.

Luo HD, Pei SN, Wang AJ, Yu XQ, Hu HJ, Zeng L, Wang FF, Jin M, Zhang X. Luo HD, et al. Among authors: yu xq. Int J Ophthalmol. 2023 Dec 18;16(12):1962-1970. doi: 10.18240/ijo.2023.12.07. eCollection 2023. Int J Ophthalmol. 2023. PMID: 38111930 Free PMC article.

3

Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3-4 COPD: A Randomized Controlled Trial.

Yu XQ, Di JQ, Zhang W, Wei GS, Ma ZP, Wu L, Yu XF, Zhu HZ, Zhou M, Feng CL, Feng JH, Fan P, Li JS, Yang JY. Yu XQ, et al. Int J Chron Obstruct Pulmon Dis. 2023 Nov 6;18:2439-2456. doi: 10.2147/COPD.S413754. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37955027 Free PMC article. Clinical Trial.

4

Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy.

Li M, Wang YN, Wang L, Meah WY, Shi DC, Heng KK, Wang L, Khor CC, Bei JX, Cheng CY, Aung T, Liao YH, Chen QK, Gu JR, Kong YZ, Lee J, Chong SA, Subramaniam M, Foo JN, Cai FT, Jiang GR, Xu G, Wan JX, Chen MH, Yin PR, Dong XQ, Feng SZ, Tang XQ, Zhong Z, Tan EK, Chen N, Zhang H, Liu ZH, Tai ES, Liu JJ, Yu XQ. Li M, et al. Among authors: yu xq. J Am Soc Nephrol. 2023 Nov 1;34(11):1900-1913. doi: 10.1681/ASN.0000000000000222. Epub 2023 Oct 2. J Am Soc Nephrol. 2023. PMID: 37787447

5

[Network Meta-analysis of oral Chinese patent medicines in treatment of acute exacerbation of chronic obstructive pulmonary disease].

Ding MY, Yang SG, Yu NX, Hong YZ, Ye ZC, Yu XQ. Ding MY, et al. Among authors: yu xq. Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(12):3373-3385. doi: 10.19540/j.cnki.cjcmm.20230226.501. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37382020 Chinese.

6

Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study.

Chen W, Liu HF, Chen QK, Zhao MH, Chen XN, Liu H, Wan JX, Li SM, Chen MH, Dai C, Shi HB, Wei JL, Zhao HW, Wang LH, Long G, Lu WH, Tang Y, Yang JW, Cao LY, Tang DX, Yang YQ, Yu XQ. Chen W, et al. Among authors: yu xq. Kidney Dis (Basel). 2022 Dec 15;9(2):82-93. doi: 10.1159/000527833. eCollection 2023 Apr. Kidney Dis (Basel). 2022. PMID: 37065610 Free PMC article.

7

Polymorphisms of CARD9 Gene Predict Disease Progression and Renal Survival of Immunoglobulin A Nephropathy.

He C, Shi D, Guo L, Zhong Z, Yu XQ, Li M. He C, et al. Among authors: yu xq. Kidney Blood Press Res. 2023;48(1):436-444. doi: 10.1159/000530262. Epub 2023 Apr 14. Kidney Blood Press Res. 2023. PMID: 37062285 Free PMC article.

8

Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese.

Shi DC, Feng SZ, Zhong Z, Cai L, Wang M, Fu DY, Yu XQ, Li M. Shi DC, et al. Among authors: yu xq. Front Immunol. 2022 Nov 24;13:1098003. doi: 10.3389/fimmu.2022.1098003. eCollection 2022. Front Immunol. 2022. PMID: 36505473 Free PMC article.

9

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial.

Li J, Yu XQ, Xie Y, Yang SG, Zhao L, Zhou M, Meng Y. Li J, et al. Among authors: yu xq. Front Pharmacol. 2022 Oct 28;13:1053356. doi: 10.3389/fphar.2022.1053356. eCollection 2022. Front Pharmacol. 2022. PMID: 36386223 Free PMC article.

10

Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese.

Shi DC, Feng SZ, Zhong Z, Cai L, Wang M, Fu DY, Yu XQ, Li M. Shi DC, et al. Among authors: yu xq. Front Immunol. 2022 Oct 13;13:973169. doi: 10.3389/fimmu.2022.973169. eCollection 2022. Front Immunol. 2022. PMID: 36311737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year